1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marentette, JO; McHowat, J; Rastogi, P; Sharma, J; Turk, J; Young, DM | 1 |
| Ishida, A; Miyakuni, Y; Nakagawa, T; Takafuji, S | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Lung endothelial cell platelet-activating factor production and inflammatory cell adherence are increased in response to cigarette smoke component exposure.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Cell Adhesion; Cell Line; Endothelial Cells; Group VI Phospholipases A2; Humans; Inflammation; Lung; Mice; Mice, Knockout; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Disease, Chronic Obstructive; Receptors, G-Protein-Coupled; Tobacco Smoke Pollution | 2012 |
Matrix metalloproteinase-9 release from human leukocytes.
Topics: Asthma; Complement C5a; Cytochalasin B; Dose-Response Relationship, Drug; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Leukocytes; Leukocytes, Mononuclear; Matrix Metalloproteinase 9; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pertussis Toxin; Platelet Activating Factor; Pulmonary Disease, Chronic Obstructive | 2003 |